Jorgensen Nathan D. 4
4 · Vor Biopharma Inc. · Filed May 10, 2023
Insider Transaction Report
Form 4
Jorgensen Nathan D.
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2023-05-08$4.14/sh−834$3,453→ 153,625 total
Footnotes (1)
- [F1]Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units ("RSUs").